Chemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and Processes
NizatidineHistamine H2 AntagonistsFamotidineGastric Acidity DeterminationFood-Drug InteractionsAnti-Ulcer AgentsSulfoxidesCisaprideBrief Psychiatric Rating ScaleCardiography, Impedance
FamotidineCimetidineIssued a nizatidine recall2020NDMAAxid AR300mgRanitidine and nizatidineMedicationCapsulesHistamineMylanReceptorLillyStomachZantacNocturnalDecreasesGastricBlockersDrugsSerum gastrinGenericDuodenalMedicationsPharmaceuticalsRecallsAcidPatientsAmountsLiver Injury1988InhibitionCapsuleOralLotsDrugTreatmentCancer
Famotidine5
  • Axid (nizatidine), Pepcid (famotidine), Tagamet (cimetidine) and Zantac (ranitidine) are some examples. (canyonranch.com)
  • 2. Rebound hypersecretion after H2-antagonist withdrawal--a comparative study with nizatidine, ranitidine and famotidine. (nih.gov)
  • 4. Comparative study of the H2-receptor antagonists cimetidine, ranitidine, famotidine and nizatidine on the rabbit stomach fundus and sigmoid colon. (nih.gov)
  • 5. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording. (nih.gov)
  • 12. Head-column field-amplified sample stacking in capillary electrophoresis for the determination of cimetidine, famotidine, nizatidine, and ranitidine-HCl in plasma. (nih.gov)
Cimetidine3
  • Despite its metabolism by the P450 system, nizatidine does not result in significant inhibitor or induction of the enzymes and thus is less likely to cause drug-drug interactions than cimetidine. (nih.gov)
  • Nizatidine has been in use for a shorter time than cimetidine or ranitidine and remains unknown whether there is cross reactivity in hepatic injury between nizatidine and other H2 blockers. (nih.gov)
  • 20. Effects of successive doses of nizatidine, cimetidine and ranitidine on serum gastrin level and gastric acid secretion. (nih.gov)
Issued a nizatidine recall2
  • Another manufacturer, Amneal Pharmaceutical, issued a nizatidine recall in April 2020. (justicecounts.com)
  • A major Canadian pharmaceutical company has issued a nizatidine recall, the latest in a string of cancer concerns related to the popular heartburn medication. (justicecounts.com)
20202
  • In January 2020, Mylan Pharmaceuticals issued a voluntary recall of certain lots of nizatidine after the heartburn medication tested positive for NDMA, a chemical which may cause cancer. (justicecounts.com)
  • An initial nizatidine recall was issued by Mylan in the United States in early 2020 after testing found elevated levels of NDMA, a potentially cancer-causing chemical. (justicecounts.com)
NDMA6
  • While Mylan has not received any reports of adverse events related to these batches to date, this product is being voluntarily recalled due to detected trace amounts of an impurity N-nitrosodimethylamine (NDMA) contained in the API Nizatidine, USP, manufactured by Solara Active Pharma Sciences Limited. (fda.gov)
  • These recalls and potential NDMA contamination may result in many nizatidine cancer lawsuits. (justicecounts.com)
  • The FDA has said that Amneal Pharmaceuticals is recalling three lots of nizatidine oral solution at the consumer level due to potential NDMA contamination. (europeanpharmaceuticalreview.com)
  • Now, nizatidine, another medication used by those here in Ohio and elsewhere for gastrointestinal issues, has been added to the list of medications recalled for NDMA. (kelley-ferraro.com)
  • In the wake of findings that Zantac may cause cancer due to NDMA contamination, scientists, doctors and patients are increasingly worried about another heartburn medication, nizatidine. (justicecounts.com)
  • On Wednesday, the FDA also announced that the drug company Mylan has recalled three lots of another antacid, nizatidine, which were also found to contain trace amounts of NDMA. (nbcnews.com)
Axid AR2
300mg2
  • Oral administration of 75 to 300mg of nizatidine increased betazole-stimulated secretion of intrinsic factor. (nih.gov)
  • Mylan N.V. (NASDAQ: MYL) today announced that its U.S. based Mylan Pharmaceuticals business is conducting a voluntary nationwide recall, to the consumer level, of three lots of Nizatidine Capsules, USP (including the 150mg and 300mg strengths). (fda.gov)
Ranitidine and nizatidine1
  • 1. Risk of Cancer in Association with Ranitidine and Nizatidine vs Other H2 Blockers: Analysis of the Japan Medical Data Center Claims Database 2005-2018. (nih.gov)
Medication3
  • The hepatic injury caused by nizatidine is usually rapidly reversible with stopping the medication, but an instance of severe hepatitis with incomplete recovery and cirrhosis has been reported (Case 1). (nih.gov)
  • Brand names of the generic medication nizatidine include Tazac and Axid . (justicecounts.com)
  • Nizatidine is the potent ingredient in this medication. (canadianpharmacyonline.com)
Capsules2
  • Nizatidine is available by prescription in capsules of 150 and 300 mg in several generic forms and in both oral and parenteral forms under the brand name Axid. (nih.gov)
  • Recalled batches include nizatidine capsules sold in bottles of 60 with an expiration date of May, as well as nizatidine capsules sold in bottles of 30 with an expiration date of January. (nbcnews.com)
Histamine7
  • Nizatidine is a histamine H2 receptor antagonist that inhibits stomach acid production, and is commonly used in the treatment of peptic ulcer disease and gastroesophageal reflux disease. (wikipedia.org)
  • Nizatidine, USP is a histamine H 2 -receptor antagonist. (nih.gov)
  • Nizatidine is a competitive, reversible inhibitor of histamine at the histamine H 2 -receptors, particularly those in the gastric parietal cells. (nih.gov)
  • Nizatidine is a histamine type 2 receptor antagonist (H2 blocker) which is widely used for treatment of acid-peptic disease and heartburn. (nih.gov)
  • Nizatidine (nye za' ti deen) was the fourth histamine type 2 receptor blocker (H2 blocker) introduced into clinical practice in the United States and is a commonly used agent for treatment of duodenal and gastric ulcer and gastroesophageal reflux disease. (nih.gov)
  • Nizatidine (brand names include Tazac, Axid and Azor ) is a histamine H2 receptor antagonist that inhibits stomach acid production. (justicecounts.com)
  • Nizatidine competitively inhibits histamine at the H2 receptor of the gastric parietal cells, resulting in reductions in gastric acid secretion, gastric volume, and hydrogen concentrations. (medscape.com)
Mylan1
  • The nizatidine recall was voluntarily issued by Mylan Pharmaceuticals Inc., a pharmaceutical company based here in the United States. (kelley-ferraro.com)
Receptor2
  • Aim: The aim of the study was to develop gastroretentive floating pellets containing H2 â€"receptor antagonist, nizatidine which is primarily absorbed from stomach and has low oral bioavailability. (asiapharmaceutics.info)
  • 15. Nocturnal acid suppression with a new H2 receptor antagonist--nizatidine. (nih.gov)
Lilly2
  • Nizatidine was developed by Eli Lilly, and was first marketed in 1988. (wikipedia.org)
  • Nizatidine was approved by the FDA in 1988 after being developed by Eli Lilly. (justicecounts.com)
Stomach4
  • Nizatidine is used to treat and prevent the recurrence of ulcers and to treat other conditions where the stomach makes too much acid. (medlineplus.gov)
  • Nizatidine also is used to treat or prevent occasional heartburn, acid indigestion, or sour stomach. (medlineplus.gov)
  • If symptoms of heartburn, acid indigestion, or sour stomach last for longer than 2 weeks while taking nizatidine, stop taking it and call your doctor. (medlineplus.gov)
  • Nizatidine is used for short-term treatment of stomach ulcers as well as heartburn caused by gastroesophageal reflux disease, the FDA wrote on its website . (nbcnews.com)
Zantac1
  • The recalls of nizatidine follow widespread Zantac cancer warnings. (justicecounts.com)
Nocturnal1
  • Nizatidine significantly inhibited nocturnal gastric acid secretion for up to 12 hours. (nih.gov)
Decreases2
  • Moderate to severe renal impairment significantly prolongs the half-life and decreases the clearance of nizatidine. (nih.gov)
  • blessed thistle decreases effects of nizatidine by pharmacodynamic antagonism. (medscape.com)
Gastric9
  • Nizatidine is used to treat duodenal ulcers, gastric ulcers, and gastroesophageal reflux disease (GERD/GORD), and to prevent stress ulcers. (wikipedia.org)
  • Nizatidine also significantly inhibited gastric acid secretion stimulated by food, caffeine, betazole, and pentagastrin (Table 1). (nih.gov)
  • Oral administration of 75 to 300 mg of nizatidine did not affect pepsin activity in gastric secretions. (nih.gov)
  • The listed indications for nizatidine are duodenal and gastric ulcer disease, gastroesophageal reflux and prevention of stress ulcers. (nih.gov)
  • Nizatidine is indicated for the short-term treatment (up to 8 weeks) of active duodenal ulcers and active benign gastric ulcers, as maintenance therapy for duodenal ulcer patients for up to one year, and for up to 12 weeks for the treatment of endoscopically diagnosed esophagitis and associated heartburn due to gastroesophageal reflux disease (GERD). (fda.gov)
  • nizatidine will decrease the level or effect of atazanavir by increasing gastric pH. (medscape.com)
  • nizatidine will decrease the level or effect of itraconazole by increasing gastric pH. (medscape.com)
  • nizatidine will decrease the level or effect of neratinib by increasing gastric pH. (medscape.com)
  • nizatidine will decrease the level or effect of pazopanib by increasing gastric pH. (medscape.com)
Blockers1
  • Chronic therapy with nizatidine and other H2 blockers is associated with minor elevations in serum aminotransferase levels in 1% to 4% of patients, but similar rates have been reported in placebo recipients. (nih.gov)
Drugs1
  • tell your doctor and pharmacist if you are allergic to nizatidine or any other drugs. (medlineplus.gov)
Serum gastrin1
  • Nizatidine had no effect on basal serum gastrin. (nih.gov)
Generic3
  • If you've been diagnosed with cancer after taking prescription nizatidine (Tazac, Axid, or Azor) or generic nizatidine, contact the nizatidine cancer attorneys at Riddle & Brantley for a FREE consultation by calling 1-800-525-7111. (justicecounts.com)
  • The former is manufactured by Pendopharm as a product of the CanadaOur generic, Nizatidine, is made by UK Generic Mfr. (canadianpharmacyonline.com)
  • In addition, you can always purchase Nizatidine, the generic alternative, instead of Axid. (qualityprescriptiondrugs.com)
Duodenal2
  • 18. 300 mg nizatidine at night versus 300 mg ranitidine at night in patients with duodenal ulcer. (nih.gov)
  • 19. Twice daily nizatidine or ranitidine is superior to once daily dosing in elevating 24 h intragastric pH in patients with duodenal ulcer disease. (nih.gov)
Medications1
Pharmaceuticals2
  • The US Food and Drug Administration (FDA) has announced that Amneal Pharmaceuticals, LLC is voluntarily recalling three lots of its nizatidine oral solution, 15mg/mL (75mg/5mL), packaged in 480mL bottles. (europeanpharmaceuticalreview.com)
  • The nizatidine oral solution was distributed by Gemini Laboratories, LLC, a wholly owned subsidiary of Amneal Pharmaceuticals. (europeanpharmaceuticalreview.com)
Recalls1
  • In the wake of these recalls, Nizatidine manufacturers may face potential lawsuits by nizatidine cancer lawyers alleging negligence and claims that they ignored warning signs. (justicecounts.com)
Acid1
  • 16. The 24-hour acid suppression profile of nizatidine. (nih.gov)
Patients2
  • Rare instances of clinically apparent liver injury have been reported in patients receiving nizatidine, but too few cases have been reported to characterize a typical time to onset or pattern of injury. (nih.gov)
  • Patients treated with nizatidine are prescribed to take it from eight weeks to one year depending on the circumstances and their medical conditions. (kelley-ferraro.com)
Amounts1
  • Because of the low levels of nizatidine in breastmilk, amounts ingested by the infant are small and would not be expected to cause any adverse effects in breastfed infants. (nih.gov)
Liver Injury1
  • Nizatidine has been linked to rare instances of clinically apparent acute liver injury. (nih.gov)
19881
  • Nizatidine was first approved for use in the United States in 1988 and is now available both by prescription and over-the-counter. (nih.gov)
Inhibition2
  • nizatidine will decrease the level or effect of infigratinib by inhibition of GI absorption. (medscape.com)
  • 10. [Inhibition of 24-hour acidity by nizatidine]. (nih.gov)
Capsule2
  • Nizatidine comes as a tablet and capsule to take by mouth. (medlineplus.gov)
  • Each nizatidine capsule USP contains for oral administration corn starch, magnesium stearate, povidone, pregelatinized starch, sodium starch glycolate and 150 mg (0.45 mmol) or 300 mg (0.91 mmol) of nizatidine USP. (nih.gov)
Oral3
  • The oral bioavailability of nizatidine is unaffected by concomitant ingestion of propantheline. (nih.gov)
  • More than 90% of an oral dose of nizatidine is excreted in the urine within 12 hours. (nih.gov)
  • Read user comments about the side effects, benefits, and effectiveness of nizatidine oral. (webmd.com)
Lots1
  • The affected nizatidine lots were distributed directly to wholesalers who further distributed to retail pharmacies and consumers nationwide in the USA. (europeanpharmaceuticalreview.com)
Drug2
  • Nizatidine is metabolized by the microsomal P450 drug metabolizing enzymes and injury may be the result of its activation to a toxic intermediate. (nih.gov)
  • Have you taken the common heartburn drug nizatidine and been diagnosed with cancer? (justicecounts.com)
Treatment1
  • 17. Nizatidine versus ranitidine in the treatment of peptic ulcer disease: report on the Dutch investigation as part of a European multicentre trial. (nih.gov)
Cancer8
  • A nizatidine cancer lawyer may be able to help with a potential nizatidine cancer lawsuit. (justicecounts.com)
  • Call 1-800-525-7111 today and let's review your nizatidine cancer claim. (justicecounts.com)
  • These cancers may qualify you for a nizatidine cancer lawsuit. (justicecounts.com)
  • A nizatidine cancer lawyer at Riddle & Brantley may be able to help. (justicecounts.com)
  • For a FREE consultation with an experienced nizatidine cancer lawyer, please call 1-800-525-7111. (justicecounts.com)
  • You may be eligible for a nizatidine claim and our nizatidine cancer attorneys would love to help you get justice if we can. (justicecounts.com)
  • Why Riddle & Brantley for your nizatidine cancer lawsuit? (justicecounts.com)
  • We believe Justice Counts for those diagnosed with cancer potentially as a result of contaminated nizatidine and we would love to help with a potential nizatidine lawsuit or claim however we can. (justicecounts.com)